| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68094-808-50 | 68094-808 | HUMAN PRESCRIPTION DRUG | Methazolamide | Methazolamide | TABLET | ORAL | 20231130 | N/A | ANDA | ANDA215615 | Precision Dose, Inc. | METHAZOLAMIDE | 50 mg/1 | 100 TABLET in 1 BOTTLE (68094-808-50) |
| 68094-908-50 | 68094-908 | HUMAN PRESCRIPTION DRUG | Methazolamide | Methazolamide | TABLET | ORAL | 20231130 | N/A | ANDA | ANDA215615 | Precision Dose, Inc. | METHAZOLAMIDE | 25 mg/1 | 100 TABLET in 1 BOTTLE (68094-908-50) |
| 51224-024-50 | 51224-024 | HUMAN PRESCRIPTION DRUG | Methazolamide | Methazolamide | TABLET | ORAL | 20220101 | N/A | ANDA | ANDA215615 | TAGI Pharma, Inc. | METHAZOLAMIDE | 25 mg/1 | 100 TABLET in 1 BOTTLE (51224-024-50) |
| 51224-124-50 | 51224-124 | HUMAN PRESCRIPTION DRUG | Methazolamide | Methazolamide | TABLET | ORAL | 20220101 | N/A | ANDA | ANDA215615 | TAGI Pharma, Inc. | METHAZOLAMIDE | 50 mg/1 | 100 TABLET in 1 BOTTLE (51224-124-50) |